DexCom

YTD

ALL

Trade DexCom 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE.

CEO

Jacob S. Leach

CEOJacob S. Leach

Employees

11,100

Employees11,100

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1999

Founded1999

Employees

11,100

Employees11,100

DXCM Key Statistics

Market cap

27.10B

Market cap27.10B

Price-Earnings ratio

30.80

Price-Earnings ratio30.80

Dividend yield

—

Dividend yield—

Average volume

8.55M

Average volume8.55M

High today

$72.65

High today$72.65

Low today

$69.92

Low today$69.92

Open price

$72.53

Open price$72.53

Volume

5.47M

Volume5.47M

52 Week high

$89.98

52 Week high$89.98

52 Week low

$54.11

52 Week low$54.11

Stock Snapshot

DexCom(DXCM) stock is priced at $70.26, giving the company a market capitalization of 27.1B. It carries a P/E multiple of 30.80.

On 2026-05-27, DexCom(DXCM) stock moved within a range of $69.92 to $72.65. With shares now at $70.26, the stock is trading +0.5% above its intraday low and -3.3% below the session's peak.

Trading volume for DexCom(DXCM) stock has reached 5.47M, versus its average volume of 8.55M.

The stock's 52-week range extends from a low of $54.11 to a high of $89.98.

DXCM News

MarketWatch 5h

DexCom Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

...

TipRanks 1d

DexCom identifies theft of scrapped Dexcom G7 sensors

DexCom (DXCM) announced through ongoing quality and accounting reviews it recently identified certain lots of Dexcom G7 sensors originally designated as scrap a...

Simply Wall St 3d

Assessing DexCom Valuation After Q1 2026 Beat Analyst Upgrades And Dexcom Flex Launch

DexCom (DXCM) has drawn fresh attention after multiple analysts shifted to “Outperform.” This coincides with robust Q1 2026 revenue of US$1.19b and the launch o...

Analyst ratings

81%

of 32 ratings

Buy

81.3%

Hold

15.6%

Sell

3.1%

More DXCM News

Simply Wall St 5d

Does DexCom’s Flex Launch in Germany Hint at a Broader CGM Access Strategy Shift?

On May 18, 2026, DexCom, Inc. launched Dexcom Flex, a continuous glucose monitoring system tailored for adults with Type 2 diabetes in Germany who are treated w...

Nasdaq 6d

DexCom Takes Over #331 Spot From First Solar

In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, DexCom Inc (Symbol: DXCM) has taken over the #331 spot...

Simply Wall St 7d

DexCom Tests Wider Type 2 CGM Adoption With German Dexcom Flex Launch

DexCom (NasdaqGS:DXCM) has launched Dexcom Flex, a continuous glucose monitoring system for adults with Type 2 diabetes in Germany. The system is aimed at pati...

People also own

Based on the portfolios of people who own DXCM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.